Gregory P. Adams - Search Results

Year	Number of Results
2001	1
2003	1
2004	4
2005	4
2006	3
2007	3
2008	5
2009	1
2011	5
2012	4
2013	4
2014	1
2015	2
2016	4
2017	1
2019	1
2020	1
2022	1
2024	0

1

Ultrasmall Folate Receptor Alpha Targeted Enzymatically Cleavable Silica Nanoparticle Drug Conjugates Augment Penetration and Therapeutic Efficacy in Models of Cancer.

Wu F, Chen PM, Gardinier TC, Turker MZ, Venkatesan AM, Patel V, Khor T, Bradbury MS, Wiesner UB, Adams GP, Germano G, Chen F, Ma K. Wu F, et al. Among authors: adams gp. ACS Nano. 2022 Dec 27;16(12):20021-20033. doi: 10.1021/acsnano.2c05342. Epub 2022 Oct 20. ACS Nano. 2022. PMID: 36264003

2

CAR T Cells Targeting MISIIR for the Treatment of Ovarian Cancer and Other Gynecologic Malignancies.

Rodriguez-Garcia A, Sharma P, Poussin M, Boesteanu AC, Minutolo NG, Gitto SB, Omran DK, Robinson MK, Adams GP, Simpkins F, Powell DJ Jr. Rodriguez-Garcia A, et al. Among authors: adams gp. Mol Ther. 2020 Feb 5;28(2):548-560. doi: 10.1016/j.ymthe.2019.11.028. Epub 2019 Dec 6. Mol Ther. 2020. PMID: 31870622 Free PMC article.

3

Molecular Simulation of Receptor Occupancy and Tumor Penetration of an Antibody and Smaller Scaffolds: Application to Molecular Imaging.

Orcutt KD, Adams GP, Wu AM, Silva MD, Harwell C, Hoppin J, Matsumura M, Kotsuma M, Greenberg J, Scott AM, Beckman RA. Orcutt KD, et al. Among authors: adams gp. Mol Imaging Biol. 2017 Oct;19(5):656-664. doi: 10.1007/s11307-016-1041-y. Mol Imaging Biol. 2017. PMID: 28213834

4

DeBouganin Diabody Fusion Protein Overcomes Drug Resistance to ADCs Comprised of Anti-Microtubule Agents.

Chooniedass S, Dillon RL, Premsukh A, Hudson PJ, Adams GP, MacDonald GC, Cizeau J. Chooniedass S, et al. Among authors: adams gp. Molecules. 2016 Dec 17;21(12):1741. doi: 10.3390/molecules21121741. Molecules. 2016. PMID: 27999336 Free PMC article.

5

Antibody Engineering & Therapeutics 2016: The Antibody Society's annual meeting, December 11-15, 2016, San Diego, CA.

Larrick JW, Alfenito MR, Scott JK, Parren PW, Burton DR, Bradbury AR, Lemere CA, Messer A, Huston JS, Carter PJ, Veldman T, Chester KA, Schuurman J, Adams GP, Reichert JM. Larrick JW, et al. Among authors: adams gp. MAbs. 2016 Nov/Dec;8(8):1425-1434. doi: 10.1080/19420862.2016.1227665. Epub 2016 Aug 24. MAbs. 2016. PMID: 27557809 Free PMC article.

6

Trastuzumab-deBouganin Conjugate Overcomes Multiple Mechanisms of T-DM1 Drug Resistance.

Dillon RL, Chooniedass S, Premsukh A, Adams GP, Entwistle J, MacDonald GC, Cizeau J. Dillon RL, et al. Among authors: adams gp. J Immunother. 2016 Apr;39(3):117-26. doi: 10.1097/CJI.0000000000000115. J Immunother. 2016. PMID: 26938945

7

Human Leukocyte Antigen-Presented Macrophage Migration Inhibitory Factor Is a Surface Biomarker and Potential Therapeutic Target for Ovarian Cancer.

Patterson AM, Kaabinejadian S, McMurtrey CP, Bardet W, Jackson KW, Zuna RE, Husain S, Adams GP, MacDonald G, Dillon RL, Ames H, Buchli R, Hawkins OE, Weidanz JA, Hildebrand WH. Patterson AM, et al. Among authors: adams gp. Mol Cancer Ther. 2016 Feb;15(2):313-22. doi: 10.1158/1535-7163.MCT-15-0658. Epub 2015 Dec 30. Mol Cancer Ther. 2016. PMID: 26719579 Free PMC article.

8

Antibody Engineering & Therapeutics 2015: The Antibody Society's annual meeting December 7-10, 2015, San Diego, CA.

Parren PW, Burton DR, Bradbury A, Huston JS, Carter PJ, Veldman T, Chester KA, Larrick JW, Alfenito MR, Scott JK, Weiner LM, Adams GP, Reichert JM. Parren PW, et al. Among authors: adams gp. MAbs. 2015;7(6):981-8. doi: 10.1080/19420862.2015.1089707. Epub 2015 Sep 30. MAbs. 2015. PMID: 26421752 Free PMC article.

9

Antibody engineering and therapeutics conference. The annual meeting of the antibody society, Huntington Beach, CA, December 7-11, 2014.

Larrick JW, Parren P, Huston JS, Plückthun A, Bradbury A, Tomlinson IM, Chester KA, Burton DR, Adams GP, Weiner LM, Scott JK, Alfenito MR, Veldman T, Reichert JM. Larrick JW, et al. Among authors: adams gp. MAbs. 2014;6(5):1115-23. doi: 10.4161/19420862.2014.971627. MAbs. 2014. PMID: 25517297 Free PMC article.

10

Anti-CD70 immunocytokines for exploitation of interferon-γ-induced RIP1-dependent necrosis in renal cell carcinoma.

Chen P, Nogusa S, Thapa RJ, Shaller C, Simmons H, Peri S, Adams GP, Balachandran S. Chen P, et al. Among authors: adams gp. PLoS One. 2013 Apr 17;8(4):e61446. doi: 10.1371/journal.pone.0061446. Print 2013. PLoS One. 2013. PMID: 23613854 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

39 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Results by year